title: Neuropsychological effects of 2-week continuous positive airway pressure treatment and supplemental oxygen in patients with obstructive sleep apnea: a randomized placebo-controlled study.
abstract: OBJECTIVE
  To determine predictors of neuropsychological functioning in patients with obstructive sleep apnea (OSA) and whether treatment with 2-week continuous positive airway pressure (CPAP) or supplemental oxygen would improve cognitive functioning.
  
  
  METHODS
  Randomized placebo-controlled design.
  
  
  METHODS
  University-based clinical research center.
  
  
  METHODS
  Forty-six patients with untreated OSA.
  
  
  METHODS
  Two-week CPAP, supplemental oxygen, or placebo-CPAP.
  
  
  RESULTS
  Participants underwent polysomnography and completed a neuropsychological test battery before and after treatment. Prior to treatment, patients with OSA showed diffuse impairments, particularly in terms of speed of information processing, attention and working memory, executive functioning, learning and memory, as well as alertness and sustained attention. A global deficit score at baseline was positively correlated with percentage of stage 1 sleep (p = .049) only and was not correlated with obesity, daytime sleepiness, depression, fatigue, OSA severity, and the other polysomnography variables. The 3 treatment groups (therapeutic-CPAP, supplemental oxygen, and placebo-CPAP) were compared using repeated-measures analysis of variance (ANOVA). There was no significant Time x Treatment interaction for the global deficit score. When examining individual neuropsychological test scores, two thirds of them improved with time regardless of treatment, although only Digit Vigilance-Time (p = .020) showed significant improvement specific to CPAP treatment.
  
  
  CONCLUSIONS
  The present results suggest that Digit Vigilance-Time might be the most sensitive neuropsychological test for measuring the effects of the treatments. In general, 2 weeks of CPAP or oxygen-supplementation treatment was insufficient to show overall beneficial cognitive effects, as compared with placebo-CPAP. However, 2 weeks of CPAP treatment might be helpful in terms of speed of information processing, vigilance, or sustained attention and alertness.
authors: Department ofPsychiatry, University of California San Diego, La Jolla, CA 92093-0804, USA.
authors: Weonjeong
authors: W
authors: Lim
authors: Wayne A
authors: WA
authors: Bardwell
authors: Jose S
authors: JS
authors: Loredo
authors: Eui-Joong
authors: EJ
authors: Kim
authors: Sonia
authors: S
authors: Ancoli-Israel
authors: Erin E
authors: EE
authors: Morgan
authors: Robert K
authors: RK
authors: Heaton
authors: Joel E
authors: JE
authors: Dimsdale
mesh_terms: D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D001288:Attention; D003071:Cognition; D045422:Continuous Positive Airway Pressure / Q000379:methods* / Q000523:psychology*; D004311:Double-Blind Method; D006801:Humans; D007858:Learning; D008570:Memory, Short-Term; D008875:Middle Aged; D009483:Neuropsychological Tests / Q000706:statistics & numerical data; D010102:Oxygen Inhalation Therapy / Q000379:methods* / Q000523:psychology; D017286:Polysomnography / Q000379:methods; D011237:Predictive Value of Tests; D020181:Sleep Apnea, Obstructive / Q000523:psychology / Q000628:therapy*; D013997:Time Factors
references: Am J Respir Crit Care Med. 1997 Dec;156(6):1813-9
references: 9412560
references: Sleep Med. 2002 Mar;3(2):139-45
references: 14592233
references: J Neurol Sci. 1998 Jul 15;159(1):45-50
references: 9700702
references: Psychosom Med. 2001 Jul-Aug;63(4):579-84
references: 11485111
references: Mt Sinai J Med. 1994 Mar;61(2):99-112
references: 8022435
references: Arch Intern Med. 1992 Mar;152(3):538-41
references: 1546916
references: Sleep. 1991 Dec;14(6):540-5
references: 1798888
references: Sleep. 2004 Jun 15;27(4):685-93
references: 15283003
references: Heart. 2001 Jan;85(1):18-22
references: 11119454
references: Chest. 1995 Sep;108(3):619-24
references: 7656606
references: J Clin Exp Neuropsychol. 1991 Nov;13(6):950-64
references: 1779033
references: Lancet. 1987 Aug 22;2(8556):447
references: 2887740
references: Ugeskr Laeger. 1995 Nov 6;157(45):6252-6
references: 7491717
references: Sleep Med Rev. 2001 Jun;5(3):223-236
references: 12530988
references: Lung. 1992;170(5):281-90
references: 1518299
references: Chest. 1999 Dec;116(6):1545-9
references: 10593774
references: J Chronic Dis. 1985;38(5):427-34
references: 3998057
references: Sleep. 1995 Jan;18(1):43-52
references: 7761742
references: Sleep. 1985;8(1):30-3
references: 3992106
references: Acta Neurol Belg. 1997 Jun;97(2):96-107
references: 9246377
references: Am J Rhinol. 2001 Sep-Oct;15(5):311-3
references: 11732817
references: Brain Res Bull. 2003 Jun 30;61(1):87-92
references: 12788211
references: Lancet. 1999 Apr 3;353(9159):1154
references: 10209985
references: J Clin Exp Neuropsychol. 1993 Mar;15(2):330-41
references: 8491855
references: Sleep. 1997 Feb;20(2):160-7
references: 9143077
references: Pneumologie. 1997 Aug;51 Suppl 3:712-5
references: 9340623
references: Anaesthesist. 2003 Jul;52(7):596-605
references: 12898044
references: Sleep. 1995 Jun;18(5):382-8
references: 7676173
references: J Clin Exp Neuropsychol. 2000 Oct;22(5):554-68
references: 11094391
references: J Sleep Res. 1999 Mar;8(1):71-6
references: 10188139
references: Chest. 1990 Aug;98(2):325-30
references: 2198135